SAFETY STUDY OF ROMIPLOSTIM BIOSIMILAR

• Main Authors: A. N. Afanasyeva (Author), V. B. Saparova (Author), D. D. Karal-Ogly (Author), E. I. Mukhametzyanova (Author), D. V. Kurkin (Author), A. V. Kalatanova (Author), I. E. Makarenko (Author), A. L. Khokhlov (Author), I. A. Lugovik (Author)
• Format: Book
• Published: Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute, 2022-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Idiopathic thrombocytopenic purpura is a chronic autoimmune hematological disease caused by an increased destruction of platelets and associated thrombocytopenia, for the treatment of which the imported drug romiplostim is used. Сreation of the drug biosimilar provides a reduction in the cost of the...